BlackRock Health Sciences Opportunities Portfolio Class R (BHSRX)
| Fund Assets | 6.53B |
| Expense Ratio | 1.44% |
| Min. Investment | $100 |
| Turnover | 43.00% |
| Dividend (ttm) | 6.76 |
| Dividend Yield | 11.44% |
| Dividend Growth | 20.83% |
| Payout Frequency | Semi-Annual |
| Ex-Dividend Date | Dec 9, 2025 |
| Previous Close | 59.11 |
| YTD Return | -4.03% |
| 1-Year Return | 7.14% |
| 5-Year Return | 23.62% |
| 52-Week Low | 54.10 |
| 52-Week High | 66.58 |
| Beta (5Y) | n/a |
| Holdings | 168 |
| Inception Date | Sep 12, 2011 |
About BHSRX
BlackRock Health Sciences Opportunities Fund Class R is a mutual fund that focuses on investments in the health sciences and related industries. Its primary objective is to provide long-term capital growth by allocating at least 80% of its assets to equity securities of companies operating within the healthcare sector, including pharmaceuticals, biotechnology, medical devices, and healthcare services. The fund diversifies its holdings across leading names such as Eli Lilly and Company, Boston Scientific, Intuitive Surgical, AbbVie, and UnitedHealth Group, reflecting its broad exposure to both established and innovative healthcare businesses. Designed to harness the growth potential in healthcare, the fund emphasizes companies with strong scientific expertise and market leadership. Managed by BlackRock’s experienced team, the fund plays a significant role for investors seeking targeted exposure to the dynamic and essential healthcare industry. With a medium share class type suitable for retirement accounts and an investment style characterized as "Large Growth," BlackRock Health Sciences Opportunities Fund Class R is recognized for its disciplined approach and commitment to risk-adjusted returns within its sector.
Performance
BHSRX had a total return of 7.14% in the past year, including dividends. Since the fund's inception, the average annual return has been 12.57%.
Top 10 Holdings
46.09% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 10.87% |
| Johnson & Johnson | JNJ | 9.52% |
| AbbVie Inc. | ABBV | 4.02% |
| Gilead Sciences, Inc. | GILD | 3.84% |
| UnitedHealth Group Incorporated | UNH | 3.22% |
| Amgen Inc. | AMGN | 3.13% |
| Merck & Co., Inc. | MRK | 3.03% |
| Thermo Fisher Scientific Inc. | TMO | 3.00% |
| Medtronic plc | MDT | 2.94% |
| Intuitive Surgical, Inc. | ISRG | 2.51% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 9, 2025 | $2.92442 | Dec 10, 2025 |
| Jul 17, 2025 | $3.83665 | Jul 18, 2025 |
| Dec 11, 2024 | $3.10427 | Dec 12, 2024 |
| Jul 18, 2024 | $2.49135 | Jul 19, 2024 |
| Dec 7, 2023 | $0.99992 | Dec 8, 2023 |
| Jul 20, 2023 | $1.34151 | Jul 21, 2023 |